Cencora (COR) Liabilities and Shareholders Equity (2009 - 2026)
Cencora (COR) posted Liabilities and Shareholders Equity of $81.7 billion for Q1 2026, up 4.2% on a QoQ basis from $78.4 billion in Q4 2025, and up 14.69% year-over-year from $71.2 billion in Q1 2025.
Cencora (COR) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends
Cencora's Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $81.7 billion for Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 14.69% year-over-year to $81.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $310.6 billion (up 13.29% YoY) and the FY2025 annual result came in at $76.6 billion, up 14.14% from the prior year.
- Liabilities and Shareholders Equity was $81.7 billion for Q1 2026 at Cencora, up from $78.4 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $81.7 billion in Q1 2026 and bottomed at $56.6 billion in Q3 2022.
- A 5-year average of $66.2 billion and a median of $64.7 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Peak annual rise in Liabilities and Shareholders Equity reached 21.92% in 2022, while the deepest fall reached 1.36% in 2022.
- Cencora's Liabilities and Shareholders Equity stood at $57.9 billion in 2022, then climbed by 11.71% to $64.7 billion in 2023, then advanced by 6.75% to $69.1 billion in 2024, then increased by 13.48% to $78.4 billion in 2025, then grew by 4.2% to $81.7 billion in 2026.
- Business Quant data shows COR's Liabilities and Shareholders Equity at $81.7 billion in Q1 2026, $78.4 billion in Q4 2025, and $76.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 82.32 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 81.65 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 56.69 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 11.30 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | 189.63 Mn |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | 310.22 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 2.42 Bn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | 72.06 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 2.31 Mn |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | 62.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.65 Bn |
| Dec 31, 2025 | 78.36 Bn |
| Sep 30, 2025 | 76.59 Bn |
| Jun 30, 2025 | 73.96 Bn |
| Mar 31, 2025 | 71.19 Bn |
| Dec 31, 2024 | 69.05 Bn |
| Sep 30, 2024 | 67.10 Bn |
| Jun 30, 2024 | 66.77 Bn |
| Mar 31, 2024 | 63.87 Bn |
| Dec 31, 2023 | 64.69 Bn |
| Sep 30, 2023 | 62.56 Bn |
| Jun 30, 2023 | 61.18 Bn |
| Mar 31, 2023 | 58.77 Bn |
| Dec 31, 2022 | 57.91 Bn |
| Sep 30, 2022 | 56.56 Bn |
| Jun 30, 2022 | 57.17 Bn |
| Mar 31, 2022 | 57.31 Bn |
| Dec 31, 2021 | 57.58 Bn |
| Sep 30, 2021 | 57.34 Bn |
| Jun 30, 2021 | 55.93 Bn |